Lipella Pharmaceuticals Inc is categorized under Commercial Medical Research in Pittsburgh, PA and active since 2005.
Lipella Pharmaceuticals Inc was established in 2005, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Jonathan H Kaufman at the company’s single location by writing to 400 North Lexington St # 103, Pittsburgh, Pennsylvania PA 15208 or by phoning (412) 901-0315. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Lipella Pharmaceuticals Inc |
| Contact Person: | Jonathan H Kaufman |
| Address: | 400 North Lexington St # 103, Pittsburgh, Pennsylvania 15208 |
| Phone Number: | (412) 901-0315 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Lipella Pharmaceuticals Inc was started in 2005 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Jonathan H Kaufman for inquiries that concern Lipella Pharmaceuticals Inc by calling the company number (412) 901-0315, as your correspondence is most welcome. Additionally, the physical location of the single location of Lipella Pharmaceuticals Inc can be found at the coordinates 40.451569,-79.897549 as well as the street address 400 North Lexington St # 103 in Pittsburgh, Pennsylvania 15208.
For its online presence, you may visit Lipella Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.